[{"NetIncomeLoss_2_Q2_USD":-29810000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":12916000.0,"InterestPaidNet_2_Q2_USD":4000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":753000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":19517000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":60000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":86145000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":37.79,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":142650.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":2958000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":1061000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":384516000.0,"OtherNoncashIncomeExpense_2_Q2_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":86947000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":71000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":0.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":173262000.0,"CommonStockSharesIssued_0_Q2_shares":27287338.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":171027000.0,"Assets_0_Q2_USD":401746000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-392000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-61000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1020000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":6972720.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"RepaymentsOfNotesPayable_2_Q2_USD":1375000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":27279000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":27271000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8972000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":38916000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17948000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":27.61,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1166000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":120000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":26000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"CommonStockValue_0_Q2_USD":27000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":14321000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-8488000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":277000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":452278.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-1268000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":2741000.0,"PrepaidRent_0_Q2_USD":200000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-29395000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-21940000.0,"OtherAssetsNoncurrent_0_Q2_USD":1354000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":221172000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":180000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":415000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-392000.0,"OperatingLeaseLiability_0_Q2_USD":1105000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":25.89,"GeneralAndAdministrativeExpense_1_Q2_USD":4687000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":61000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2478000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":961000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-34722000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":676000.0,"LiabilitiesCurrent_0_Q2_USD":20130000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":50155000.0,"AccountsPayableCurrent_0_Q2_USD":6289000.0,"NonoperatingIncomeExpense_2_Q2_USD":3078000.0,"NonoperatingIncomeExpense_1_Q2_USD":1087000.0,"InterestExpense_2_Q2_USD":0.0,"InterestExpense_1_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":221232000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6638000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":107000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":212000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0859,"SecurityDeposit_0_Q2_USD":300000.0,"AdditionalPaidInCapital_0_Q2_USD":654492000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":32256.0,"OperatingLeasePayments_2_Q2_USD":478000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":25000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":12530000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1495000.0,"NetIncomeLoss_1_Q2_USD":-21548000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4940000.0,"CommonStockSharesOutstanding_0_Q2_shares":27287338.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-273836000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1365178.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":15000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-32888000.0,"OperatingIncomeLoss_1_Q2_USD":-22635000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-29810000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-21548000.0,"NotesPayableCurrent_0_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":156706000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.28,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.31,"OperatingLeaseCost_2_Q2_USD":440000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":490000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":401746000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6435000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":925000.0,"OperatingExpenses_2_Q2_USD":47888000.0,"OperatingExpenses_1_Q2_USD":22635000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.09,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.79,"OtherLiabilitiesNoncurrent_0_Q2_USD":180000.0,"OtherLiabilitiesCurrent_0_Q2_USD":925000.0,"StockholdersEquity_0_Q2_USD":381436000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":170000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":170067000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2697996.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2036000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":542000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO, INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]